GAO-25-107110
GAO is making two recommendations: that the Secretary of Health and Human Services (1) identify and implement a mechanism to formally coordinate its drug shortage activities and collaborate with other federal stakeholders, and (2) ensure this mechanism takes GAO leading practices for collaboration into consideration.
When HHS was provided a draft of this report for review, GAO recommended that the coordinator document how GAO’s leading practices will be used for coordinating across the federal government to help address drug shortages. In written comments, HHS stated that it did not concur with GAO’s recommendation, as the coordinator position and its associated actions would be ending in May 2025. Consistent with this new information, GAO revised its recommendation, as stated above.
Not Yet a Premium Partner/Sponsor? Learn more about the OS AI Premium Corporate and Individual Plans here. Plans start at $295 annually.